QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01E PROTEIN KINASE INHIBITORS
QL01EA BCR-ABL tyrosine kinase inhibitors
QL01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
QL01EC B-Raf serine-threonine kinase (BRAF) inhibitors
QL01ED Anaplastic lymphoma kinase (ALK) inhibitors
QL01EE Mitogen-activated protein kinase (MEK) inhibitors
QL01EF Cyclin-dependent kinase (CDK) inhibitors
QL01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
QL01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
QL01EJ Janus-associated kinase (JAK) inhibitors
QL01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
QL01EL Bruton's tyrosine kinase (BTK) inhibitors
QL01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
QL01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
QL01EX Other protein kinase inhibitors
Last updated: 2024-01-17